Bausch Health (TSX:BHC) Issuance of Debt : C$407 Mil (TTM As of Sep. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Issuance of Debt?

Bausch Health's Issuance of Debt for the three months ended in Sep. 2024 was C$0 Mil.

Bausch Health's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was C$407 Mil.

Bausch Health Issuance of Debt Historical Data

The historical data trend for Bausch Health's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Issuance of Debt Chart

Bausch Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Issuance of Debt

Get a 7-Day Free Trial

7,864.53

4,426.79

2,688.00

9,286.71

4,415.21

Bausch Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Issuance of Debt	Get a 7-Day Free Trial															3,639.84	195.87	101.52	109.64	-

Bausch Health Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$407 Mil.

Bausch Health Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Bausch Health's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

BHC:USA BHC:Mexico BVF:Germany BVF:Germany

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Executives

Seana Lynne Carson	Senior Officer
Robert Allen Spurr	Senior Officer
Joseph Gordon	Senior Officer
Steven Daniel Miller	Director
Andrew Charles Von Eschenbach	Director
Richard Urbain De Schutter	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler	Director
William Douglas Humphries	Senior Officer
John Paulson	Director
Thomas Ross Sr.	Director
Christina Ackermann	Senior Officer
Joseph Papa	Director, Senior Officer
Paul Herendeen	Senior Officer